India to Poland: Pioglitazone Export Trade Route
India has recorded 86 verified shipments of Pioglitazone exported to Poland, representing a combined trade value of $649.6K USD. This corridor is served by 3 active Indian exporters, with an average shipment value of $7.6K USD. The leading Indian exporter is INTAS PHARMACEUTICALS LIMITED, which accounts for 75% of total export value with 52 shipments worth $484.8K USD. On the buying side, BIOTON S.A. is the largest importer in Poland with $200.4K USD in purchases. The top 3 suppliers — INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LIMITED , INTAS PHARMACEUTICALS LTD — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Poland Pioglitazone corridor is one of India's established pharmaceutical export routes, with 86 shipments documented worth a combined $649.6K USD. The route is dominated by INTAS PHARMACEUTICALS LIMITED, which alone accounts for roughly 75% of all export value, reflecting the consolidated nature of India's pioglitazone manufacturing sector.
Across 3 active suppliers, the average shipment value stands at $7.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 81% of all shipments, consistent with pioglitazone's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 18 days port-to-port. The route has recorded an annual growth rate of 16.8%, placing it at rank #6 among India's top pioglitazone export destinations globally.
On the import side, key buyers of Indian pioglitazone in Poland include BIOTON S.A., BIOTON S A, ACCORD HEALTHCARE POLSKA SP Z O O and 9 others. BIOTON S.A. is the single largest importer with 22 shipments valued at $200.4K USD.
Route Characteristics
- Average transit18 days
- Peak seasonQ2
- Primary modeSea freight
- Top portMUNDRA SEA (INMUN1)
Market Position
- Global rank#6
- Annual growth+16.8%
- Demand growth+14.5%
- Regulatory ease85/100
Top 10 Indian Pioglitazone Exporters to Poland
Showing top 10 of 3 Indian suppliers exporting Pioglitazone to Poland, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | INTAS PHARMACEUTICALS LIMITED Avg $9.3K per shipment | 52 | $484.8K | 74.6% |
| 2 | INTAS PHARMACEUTICALS LIMITED Avg $2.9K per shipment | 31 | $91.1K | 14.0% |
| 3 | INTAS PHARMACEUTICALS LTD Avg $24.6K per shipment | 3 | $73.7K | 11.3% |
This table shows the top 10 of 3 Indian companies exporting pioglitazone to Poland, ranked by total trade value. The listed exporters are: INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LIMITED , INTAS PHARMACEUTICALS LTD. INTAS PHARMACEUTICALS LIMITED is the dominant supplier with 52 shipments worth $484.8K USD, giving it a 75% market share.
Top 10 Pioglitazone Importers in Poland
Showing top 10 of 12 known buyers in Poland receiving Pioglitazone shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian pioglitazone in Poland include BIOTON S.A., BIOTON S A, ACCORD HEALTHCARE POLSKA SP Z O O, ACCORD HEALTHCARE POLSKA SP. Z.O.O., Bioton S A, among 12 total buyers. The largest importer is BIOTON S.A., accounting for $200.4K USD across 22 shipments — representing 31% of all pioglitazone imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | BIOTON S.A. | 22 | $200.4K | 30.9% |
| 2 | BIOTON S A | 4 | $80.1K | 12.3% |
| 3 | ACCORD HEALTHCARE POLSKA SP Z O O | 7 | $79.1K | 12.2% |
| 4 | ACCORD HEALTHCARE POLSKA SP. Z.O.O. | 11 | $62.4K | 9.6% |
| 5 | Bioton S A | 2 | $59.5K | 9.2% |
| 6 | ACCORD HEALTHCARE POLSKA SP.Z.O.O. | 14 | $51.1K | 7.9% |
| 7 | TO THE ORDER., | 4 | $49.8K | 7.7% |
| 8 | ACCORD HEALTHCARE POLSKA SP. Z.O.O. | 15 | $35.0K | 5.4% |
| 9 | ACCORD HEALTHCARE POLSKA SP ZOO MAGAZYN IMPORTERA UL LUTOMIERSKA | 1 | $14.2K | 2.2% |
| 10 | ACCORD HEALTHCARE POLSKA SP. Z O.O. | 2 | $7.1K | 1.1% |
Showing top 10 of 12 Pioglitazone importers in Poland on this route.
Top 10 Pioglitazone Formulations Imported by Poland
Showing top 10 of 42 product formulations shipped on the India to Poland Pioglitazone route, ranked by trade value
Poland imports a wide range of pioglitazone formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — PH. DRU & MEDI PIOGLITAZONE 30MG 2X14T(EACH UNCOATED TAB. CONTAINS PIOGLITAZONE HYDROCHLORIDE EQ.TOPIOGLITAZONE 30MGTBS — accounts for $101.0K USD across 12 shipments. There are 42 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | PH. DRU & MEDI PIOGLITAZONE 30MG 2X14T(EACH UNCOATED TAB. CONTAINS PIOGLITAZONE HYDROCHLORIDE EQ.TOPIOGLITAZONE 30MGTBS | 12 | $101.0K | 15.5% |
| 2 | PH. DRU & MEDI. PIOGLITAZONE 15MG 2X14T(EACH UNCOATED TABLET CONTAINS PIOGLITAZONE HYDROCHLORIDE EQ.PIOGLITAZONE 15MGTBS | 6 | $80.8K | 12.4% |
| 3 | PHARMACEUTICAL DRUGS & MEDICINE-PIOGLITAZONE 30MG 2X14T Each uncoated tablet contains Piogl..Hyd.eq.to Pioglitazone.30mg | 1 | $59.4K | 9.2% |
| 4 | PH.DRU.& MED.: PIOGLITAZONE 15MG TABLETS | 3 | $46.8K | 7.2% |
| 5 | PH.DRU.& MED.: PIOGLITAZONE 30MG TABLETSEACH TABLET CONTAINS: PIOGLITAZONE HCLEQ. TO. PIOGLITAZONE 30MG [2X14T PER P | 1 | $33.3K | 5.1% |
| 6 | PHARMA DRUGS & MEDI PIOGLITAZONE ACCORD15 MG AS PER INVOICE | 1 | $27.8K | 4.3% |
| 7 | PHARMA DRUGS & MEDI Pioglitazone Accord 15 mg AS PER DOCUMENT | 1 | $27.8K | 4.3% |
| 8 | PH.DRU.& MED.: PIOGLITAZONE 15MG TABLETS(EACH TABLET CONTAINS: PIOGLITAZONE HCLEQ. TO. PIOGLITAZONE 15MG) [2X14T PER P | 2 | $26.7K | 4.1% |
| 9 | PH.DRU.& MED.: PIOGLITAZONE 45MG TABLETS(EACH TABLET CONTAINS: PIOGLITAZONE HCLEQ. TO. PIOGLITAZONE 45MG) [2X14T PER P | 2 | $23.1K | 3.6% |
| 10 | PHARMA DRUGS & MEDI PIOGLITAZONE 30MG 2X15T (ACCORD-ROMANIA AS PER INVOICE | 1 | $20.0K | 3.1% |
Showing top 10 of 42 Pioglitazone formulations imported by Poland on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 81%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
MUNDRA SEA (INMUN1) handles the highest volume with 35 shipments. Transit time averages 18 days by sea.
Market Dynamics
India's pioglitazone exports to Poland are driven primarily by a handful of large-scale manufacturers. INTAS PHARMACEUTICALS LIMITED with 52 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in Poland benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LIMITED , INTAS PHARMACEUTICALS LTD — together account for 100% of total trade value on this route. The average shipment value of $7.6K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as ph. dru & medi. pioglitazone 15mg 2x14t(each uncoated tablet contains pioglitazone hydrochloride eq.pioglitazone 15mgtbs and pharmaceutical drugs & medicine-pioglitazone 30mg 2x14t each uncoated tablet contains piogl..hyd.eq.to pioglitazone.30mg, suggesting that buyers in Poland tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, BIOTON S.A. is the largest importer with 22 shipments worth $200.4K USD — representing 31% of all pioglitazone imports from India on this route. A total of 12 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $649.6K
- Avg. Shipment
- $7.6K
- Suppliers
- 3
- Buyers
- 12
- Transit (Sea)
- ~18 days
- Annual Growth
- +16.8%
Related Analysis
Other Pioglitazone Routes
Unlock the Full India to Poland Pioglitazone Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 86 shipments on this route.
Frequently Asked Questions — India to Poland Pioglitazone Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Pioglitazone to Poland?
The leading Indian exporters of Pioglitazone to Poland are INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LIMITED , INTAS PHARMACEUTICALS LTD. INTAS PHARMACEUTICALS LIMITED holds the largest market share at approximately 75% of total trade value on this route.
Q What is the total value of Pioglitazone exports from India to Poland?
India exports Pioglitazone to Poland worth approximately $649.6K USD across 86 recorded shipments. The average value per shipment is $7.6K USD.
Q Which ports does India use to ship Pioglitazone to Poland?
The most active port of origin is MUNDRA SEA (INMUN1) with 35 shipments. Indian exporters primarily use sea freight for this route, with 81% of shipments going by sea and 27% by air.
Q How long does shipping take from India to Poland for Pioglitazone?
The average transit time for Pioglitazone shipments from India to Poland is approximately 18 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to Poland Pioglitazone trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 16.8% with demand growth tracking at 14.5%. The route is ranked #6 among India's top Pioglitazone export destinations globally.
Q How many suppliers are active on the India to Poland Pioglitazone route?
There are currently 3 active Indian suppliers exporting Pioglitazone to Poland. The market is moderately concentrated with INTAS PHARMACEUTICALS LIMITED accounting for 75% of total shipment value.
Q Who are the main importers of Pioglitazone from India in Poland?
The leading importers of Indian Pioglitazone in Poland include BIOTON S.A., BIOTON S A, ACCORD HEALTHCARE POLSKA SP Z O O, ACCORD HEALTHCARE POLSKA SP. Z.O.O., Bioton S A. BIOTON S.A. is the largest buyer with 22 shipments worth $200.4K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Poland export trade corridor identified from Indian Customs (DGFT) records for Pioglitazone.
- 2.Supplier/Buyer Matching: 3 Indian exporters and 12 importers in Poland matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 86 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
86 Verified Shipments
3 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists